Cite
HARVARD Citation
Belfrage, A. et al. (2016). Discovery of pyrazinone based compounds that potently inhibit the drug-resistant enzyme variant R155K of the hepatitis C virus NS3 protease. Bioorganic & medicinal chemistry. 24 (12), pp. 2603-2620. [Online].